Early Therapy May Keep HIV Patients Healthy
They say timing is everything — and that may apply to HIV treatment. Starting antiretroviral therapy early may keep HIV patients healthy.
On World AIDS Day, Organizers Focus on Raising Awareness
Today is World AIDS Day, a special day to raise awareness about HIV and AIDS and to bring people together in the fight against the epidemic. This year's theme is "Focus, Partner, Achieve: An AIDS-Free Generation."
HIV Patients Not Receiving Regular Care
With new medications and treatments, HIV therapy has dramatically improved over the past two decades. Many with the virus, however, may not be getting proper treatment.
Gilead Announces Harvoni Results from Phase 2 and Phase 3 Studies
Gilead Sciences, Inc. (Nasdaq: GILD) today announced results from several Phase 2 and Phase 3 studies evaluating investigational uses of Harvoni® (ledipasvir 90 mg/sofosbuvir 400 mg) for the treatment of chronic hepatitis C virus (HCV) infection in patients with limited or no treatment options, including patients with decompensated cirrhosis, patients with HCV recurrence following a liver transplant and patients who failed previous treatment with other direct acting antivirals.
Hepatitis C Patients May Live Longer With Treatment
For patients with chronic hepatitis C, liver problems can sometimes shorten their lives. But a new study found that successful treatment might ease some life expectancy concerns for these patients.
FDA Approves Combo Treatment for Hepatitis C
The US Food and Drug Administration (FDA) approved a new combination treatment for hepatitis C infection Wednesday.
Hepatitis C Rx Gets Additional Approval as Combo Treatment with Sofosbuvir
Janssen Therapeutics, Division of Janssen Products, LP (Janssen) announced the U.S. Food and Drug Administration (FDA) has approved OLYSIO® (simeprevir), a hepatitis C virus (HCV) NS3/4A protease inhibitor, in combination with sofosbuvir as an all-oral, interferon- and ribavirin-free treatment option for genotype 1 chronic hepatitis C (CHC) infection in adult patients as part of a combination antiviral treatment regimen.
FDA Approves New Combo Rx for Hepatitis C
US regulators have approved a new pill to treat hepatitis C. That pill, which is a combination of two medications, could simplify treatment for patients.
FDA Approves First Combination Pill to Treat Hepatitis C
The U.S. Food and Drug Administration today approved Harvoni (ledipasvir and sofosbuvir) to treat chronic hepatitis C virus (HCV) genotype 1 infection.
Researchers Find Possible Link Between Tobacco and Oral HPV
Smoking has been tied to health issues of all types. Now, smokers might have another reason to kick the habit — oral human papillomavirus (HPV).